Advanced Antimicrobial Stewardship Curriculum for Fellows

The IDSA Advanced Antimicrobial Stewardship (AS) curriculum provides you with the knowledge and skills to become a leader in antimicrobial stewardship and is intended for those who are considering or actively pursuing a career in antimicrobial stewardship. It builds upon the IDSA CORE AS Curriculum, which provides fellows with a broad foundation in antimicrobial stewardship.

As with the CORE curriculum, the Advanced curriculum is designed for use at your home institution and builds on local AS resources. The content is organized into 5 main sections and includes eLearning modules, workbooks, and application activities.

Target Audience

Fellows/Trainees interested in leading an Antimicrobial Stewardship Program.

Learning Objectives

Upon completion of this section, you will be able to:

Develop a comprehensive antimicrobial stewardship program by defining overall goals, optimizing team structure, and carrying out regulatory and reporting aspects of stewardship
Analyze local microbiology and antimicrobial data and use it to identify and implement impactful antimicrobial stewardship initiatives
Apply behavioral psychology principles and leverage business principles to increase resources for antimicrobial stewardship and influence culture change by creating effective programmatic antimicrobial stewardship communication approaches
Evaluate and plan the most effective diagnostic and antibiotic stewardship interventions for unique populations and settings (specifically the emergency department, immunocompromised populations, long-term care facilities, and outpatient sites)
Identify resources for professional development in antimicrobial stewardship to be able to begin a career in antimicrobial stewardship
Develop a plan to expand the reach of a stewardship program into the outpatient setting and effectively collaborate with OPAT programs to optimize stewardship efforts

Additional Information

Attachment	Size
CORE/Advanced AS Curriculum Flyer	172.72 KB
Institutional Purchasing for the AS Curriculum	514.96 KB
Enrolling As a Fellow or Faculty With a Code	409.08 KB

Course summary

Course opens:

07/01/2020

Course expires:

07/31/2025

IDSA Member cost:

$125.00

Non-member cost:

$175.00

Cost:

$175.00

Advanced AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found.

All relevant financial relationships have been mitigated.

Name	Individual's role in activity	Name of commercial interest	Nature of Relationship
Advani, Sonali	Workgroup Member	None
Armstrong, Wendy	Workgroup Member	None
Barsoumian, Alice	Workgroup Member	None
Beeler, Cole	Workgroup Member	None
Bennani, Kenza	Staff	None
Blair, Barbra	Workgroup Member	None
Brennan - Krohn, Thea	Workgroup Member	None
Bryson - Cahn, Chloe	Workgroup Member	None
Cherabuddi, Kartik	Workgroup Member	None
Fong, Gary	Workgroup Member	Critical Innovations, LLC	Advisory/Consultant Role
Gaston, David	Workgroup Member	None
Hamilton, Keith	Workgroup Member	None
Holubar, Marisa	Workgroup Member	None
Huang, Misha	Workgroup Member	None
Ince, Dilek	Workgroup Member	Gilead Science’s Clinical Studies for remdesivir	Principal Investigator
		Accelerate Diagnostics	Research Grants/Contracts
		Leidos	Research Grants/Contracts
Justo, Julie Ann	Workgroup Member	bioMerieux	Other remuneration - Speaker's Bureau
		Merck	Advisory/Consultant Role
		Vaxart	Stocks/Bonds
Kang, Amy	Workgroup Member	None
Larnard, Jeff	Workgroup Member	None
Lee, Matthew	Workgroup Member	None
Logan, Ashleigh	Staff	None
Luther, Vera	Workgroup Member	None
MacDougal, Conan	Workgroup Member	None
Melia, Michael	Workgroup Member	Merck	Organizational Benefit
		Allergan	Organizational Benefit
		Pfizer; Melinta	Organizational Benefit
Miller, Matt	Workgroup Member	Abbvie	Honoraria
		La Jolla	Honoraria
		Merck	Research Grant/Contract
Moenster, Ryan	Workgroup Member	Shionogi	Advisory/Consultant Role, Honoraria
		Abbvie/Allergan	Advisory/Consultant Role, Honoraria
		Melinta Therapeutics	Advisory/Consultant Role, Honoraria
		Merck	Advisory/Consultant Role, Honoraria
Nori, Priya	Workgroup Member	Merck	Co-infections in COVID-19 patients
Paras, Molly	Workgroup Member	None
Patel, Payal	Workgroup Member	None
Rodvold, Keith	Workgroup Member	BLC USA LP	Advisory/Consultant Role, Honoraria
		VenatoRx	Advisory/Consultant Role, Honoraria
		Medicine Company/Qpex Biopharma	Advisory/Consultant Role, Honoraria
		Vemco Med Ed. (Merck CME/CPE programs)	Advisory/Consultant Role, Honoraria
		Debipharm	Advisory/Consultant Role, Honoraria
		Shionogi	Advisory/Consultant Role, Honoraria
			Unrestricted education grant for CME/CPE Program
		Utility Therapeutics	Advisory/Consultant Role, Honoraria
		Janssen	Data Safety Monitoring Board (DSMB)
		Clinartis LLC (projects associated with Spero Therapeutics and Sinovent)	Advisory/Consultant Role, Honoraria
		USCAST : US Ctte on Antimicrobial Susceptibility Testing	Voting Committee Member
Schooneveld, Trevor	Workgroup Member	Rebiotix, Merk	Research Grant
		Thermo - Fischer	Speaking
Schwartz, Brian	Workgroup Member	None
Spicer, Jennifer	Workgroup Member	None
Stack, Conor	Workgroup Member	None
Stead, Wendy	Workgroup Member	None
Stohs, Erica	Workgroup Member	Reviral Ltd	Research Grant
Wiley, Zanthia	Workgroup Member	None
Willis, Zachary	Workgroup Member	None
Shnekendorf, Rachel	Staff	None
Vaezi, Liza	Workgroup Member	None
Rachel Simmons	Reviewer	None